Julie Andrews

Julie Andrews joined Orthofix in 2024 and serves as Chief Financial Officer (CFO). Ms. Andrews previously served as CFO for Smart Wires Technology, a global transmission grid technology company focused on enabling the transition to renewable energy. Prior to this, Ms. Andrews served as the Senior Vice President, Global Finance for Wright Medical Group, a global medical device company focused on extremities and biologics that was acquired by Stryker in 2020. A seasoned executive, Ms. Andrews also spent many years in roles of increasing responsibility at Medtronic Inc. including Vice President of Finance for the Spine and Biologics division, where she provided oversight of all financial planning and analysis and accountings functions. Early in her career, Ms. Andrews served as a Senior Financial Analyst for Thomas & Betts and as an auditor for Thomas Havey, LLC. Currently she serves on the Board and as Chair of the Audit Committee of RxSight, Inc., an ophthalmic medical device company. Ms. Andrews received a Bachelor of Science in Accounting from Indiana University. She also participated in advanced leader and director development programs at both Medtronic and Wharton School of Business.